NASDAQ$ACHC

Acadia Healthcare Company Inc. · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Acadia Healthcare reported strong first quarter results, driven by revenue growth and strategic investments.

Acadia Healthcare reported a strong start to 2021, with revenue increasing by 8.2% to $551.2 million. The company's same facility revenue grew by 7.4%, and adjusted EBITDA was $119.5 million. Acadia is focused on strategic investments in facility expansions, de novo facilities, and joint venture partnerships to drive long-term growth.

  • Revenue increased by 8.2% to $551.2 million compared to Q1 2020.
  • Same facility revenue grew by 7.4% compared to Q1 2020.
  • Adjusted EBITDA was $119.5 million, compared to $96.7 million in the same period last year.
  • The company completed debt refinancing actions in March 2021.

Headline financials

Total Revenue

$551M

Previous: $783M-29.6%
EPS (adj)

$0.47

Previous: $0.42+11.9%
US Same-Facility Rev. Growth

7.4%

Previous: 4.1%+80.5%
US Same-Facility Patient Days Growth

2.7%

Previous: 2.9%-6.9%
US Same-Facility Admissions Growth

0.8%

No prior period
US Same-Facility Rev/Day Growth

4.5%

Previous: 1.2%+275.0%
Capital Expenditures

-$58.7M

Previous: -$69.5M+15.6%
Free Cash Flow

-$49M

Previous: -$36.1M-35.7%
Net Income

$9.72M

Previous: $33.5M-71.0%
Operating Income

-$153M

Previous: $133M-215.4%
Gross Profit

$226M

Previous: $311M-27.4%
Cash & Equivalents

$179M

Previous: $81M+120.9%
Total Assets

$4.53B

Previous: $6.72B-32.6%
Stock-Based Comp

$7.03M

Previous: $4.98M+41.3%

Revenue & EPS history

Acadia Healthcare · Revenue · Quarterly

$551M

Q1 2021-29.6%vs Q1 2020
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Forward guidance

Acadia increased its financial guidance for 2021.

Tailwinds

  • Revenue in a range of $2.24 billion to $2.29 billion
  • Adjusted EBITDA in a range of $500 million to $530 million
  • Adjusted earnings per diluted share in a range of $2.30 to $2.55
  • Interest expense of approximately $17 million per quarter for the remainder of 2021

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+1.5%

Avg return

Earnings day

+1.4%

Avg return

5 days after

+2.5%

Avg return

30 days after

60%

38 / 63 earnings

Positive

+23.1%

Q3 2020

Best reaction

-26.9%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.5%+0.3%-16.0%
Q4 2025+21.4%+36.5%+33.4%
Q3 2025-5.5%-10.2%-25.2%
Q1 2025+4.2%+1.2%-14.4%
Q4 2024-25.5%-26.3%-25.2%
Q3 2024-17.3%-18.0%-21.3%
Q2 2024+10.0%+5.4%+21.6%
Q1 2024-9.8%-8.3%-6.8%
Q4 2023-2.4%-1.8%-7.3%
Q3 2023-1.7%+1.1%+0.5%
Q2 2023+7.8%+6.5%+2.9%
Q1 2023-1.3%-4.4%-6.0%
Q4 2022-9.6%-7.3%-12.1%
Q3 2022-3.4%-5.5%+7.2%
Q2 2022+3.6%+3.9%+4.8%
Q1 2022+8.0%+5.4%+6.4%
Q4 2021+6.5%+9.3%+15.3%
Q3 2021+10.5%+11.8%+3.0%
Q2 2021+3.1%+1.3%+8.0%
Q1 2021-1.1%+1.1%+4.4%
Q4 2020+1.5%+2.5%+6.0%
Q3 2020+23.1%+28.7%+49.1%
Q2 2020+2.3%+2.7%-0.1%
Q1 2020+16.7%+18.2%+26.7%
Q4 2019-5.9%+6.0%+100.5%
Q3 2019-3.5%-2.0%+2.5%
Q2 2019-3.3%-12.0%-19.6%
Q1 2019+0.0%+3.2%+1.4%
Q4 2018+15.9%+11.7%+11.7%
Q3 2018-12.8%-5.0%-26.0%
Q2 2018-10.6%-7.4%-8.0%
Q1 2018+9.0%+11.7%+13.0%
Q4 2017+8.5%+6.8%+8.4%
Q3 2017-26.9%-25.6%-30.7%
Q2 2017+7.6%+5.7%-7.5%
Q1 2017-3.1%+0.0%-2.4%
Q4 2016+5.4%+4.9%-1.7%
Q3 2016+3.1%+3.8%+5.9%
Q2 2016-1.3%-0.8%-4.8%
Q1 2016-0.8%
Q4 2015+5.7%
Q3 2015+9.4%
Q2 2015+3.4%
Q1 2015-2.9%
Q4 2014-0.4%
Q3 2014+11.2%
Q2 2014-2.1%
Q1 2014+0.4%
Q4 2013-2.8%
Q3 2013+9.0%
Q2 2013+8.2%
Q1 2013+2.9%
Q4 2009+2.3%
Q4 2012+0.1%
Q3 2012+2.3%
Q2 2012+7.5%
Q2 2011+4.4%
Q1 2012+6.5%
Q1 2011-1.0%
Q4 2011+3.3%
Q4 2010+0.1%
Q3 2011+0.1%
Q3 2010+0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro